MD Anderson - Institute for Personalized Cancer Therapy

Member Type: Research & Educational Institutions 

The MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy was created to support preclinical research and clinical trials in which a patient’s tumor biopsy is assayed for abnormal genes and gene products to select therapy with agents targeting the product of those particular abnormal genes. This integrated research and clinical trials program is aimed at implementing personalized cancer therapy and improving patient outcomes.

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today

Download a Member List